English
简体中文
Total: £ 56.28
Published Date: 2025-10-21 | Pages: 162 | Tables: 152 | Medical Devices & Consumables
The global Liquid Embolic Materials market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Liquid embolic materials are a kind of interventional treatment material widely used in the medical field. They mainly refer to a class of fluid-like preparations that are directly injected into the target tissue or blood vessel through a microcatheter to achieve the purpose of embolization, isolation or treatment of lesions. After injection, this type of material can react with water or other components in the blood, quickly precipitate and coagulate to form an embolism, thereby blocking the blood flow or blood supply to the lesion area. The main components of liquid embolic materials vary from product to product, but usually include embolic agents, solvents, and developers, etc. According to the different adhesion, liquid embolic materials can also be divided into two categories: adhesive liquid embolic materials and non-adhesive liquid embolic materials.
As an important part of the embolization therapy market, the market size of liquid embolic agents is expanding with the increase in the number of patients with vascular diseases. In particular, in the treatment of diseases such as neurovascular malformations, aneurysms, arteriovenous malformations and tumors, liquid embolic agents are used more and more widely. In addition, with the acceleration of the aging process of the population and the increase in the incidence of chronic diseases such as cardiovascular diseases and tumors, the demand for liquid embolic materials is also increasing. In particular, the incidence of diseases such as neurovascular malformations has increased year by year, further promoting the development of the liquid embolic agent market. In summary, the liquid embolic material market is in a rapid development stage, and in the future, the liquid embolic material market will usher in a broader development prospect.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Liquid Embolic Materials market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
Boston Scientific
MTI Onyx
Johnson & Johnson
BALT Extrusion
Merit Medical Systems
Guerbet
Terumo
Penumbra
Sirtex
Sexs Biotech
Zhuhai Shenping Medical
Yuanda Pharmaceutical
Segment by Type
Adhesive
Non-adhesive
Segment by Application
Neurovascular Interventional Treatment
Tumor Interventional Treatment
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Liquid Embolic Materials study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Liquid Embolic Materials: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Liquid Embolic Materials Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Adhesive
1.2.3 Non-adhesive
1.3 Market Segmentation by Application
1.3.1 Global Liquid Embolic Materials Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Neurovascular Interventional Treatment
1.3.3 Tumor Interventional Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Liquid Embolic Materials Revenue Estimates and Forecasts 2020-2031
2.2 Global Liquid Embolic Materials Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Liquid Embolic Materials Sales Estimates and Forecasts 2020-2031
2.4 Global Liquid Embolic Materials Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Liquid Embolic Materials Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Liquid Embolic Materials Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Adhesive Market Size by Manufacturers
3.5.2 Non-adhesive Market Size by Manufacturers
3.6 Global Liquid Embolic Materials Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Liquid Embolic Materials Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Liquid Embolic Materials Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Liquid Embolic Materials Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Liquid Embolic Materials Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Liquid Embolic Materials Sales and Revenue by Type (2020-2031)
6.4 North America Liquid Embolic Materials Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Liquid Embolic Materials Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Liquid Embolic Materials Sales and Revenue by Type (2020-2031)
7.4 Europe Liquid Embolic Materials Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Liquid Embolic Materials Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Liquid Embolic Materials Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Liquid Embolic Materials Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Liquid Embolic Materials Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Liquid Embolic Materials Sales and Revenue by Type (2020-2031)
9.4 Central and South America Liquid Embolic Materials Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Liquid Embolic Materials Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Liquid Embolic Materials Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Liquid Embolic Materials Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Liquid Embolic Materials Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Liquid Embolic Materials Product Models, Descriptions and Specifications
11.1.4 Medtronic Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Liquid Embolic Materials Sales by Product in 2024
11.1.6 Medtronic Liquid Embolic Materials Sales by Application in 2024
11.1.7 Medtronic Liquid Embolic Materials Sales by Geographic Area in 2024
11.1.8 Medtronic Liquid Embolic Materials SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Liquid Embolic Materials Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Boston Scientific Liquid Embolic Materials Sales by Product in 2024
11.2.6 Boston Scientific Liquid Embolic Materials Sales by Application in 2024
11.2.7 Boston Scientific Liquid Embolic Materials Sales by Geographic Area in 2024
11.2.8 Boston Scientific Liquid Embolic Materials SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 MTI Onyx
11.3.1 MTI Onyx Corporation Information
11.3.2 MTI Onyx Business Overview
11.3.3 MTI Onyx Liquid Embolic Materials Product Models, Descriptions and Specifications
11.3.4 MTI Onyx Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 MTI Onyx Liquid Embolic Materials Sales by Product in 2024
11.3.6 MTI Onyx Liquid Embolic Materials Sales by Application in 2024
11.3.7 MTI Onyx Liquid Embolic Materials Sales by Geographic Area in 2024
11.3.8 MTI Onyx Liquid Embolic Materials SWOT Analysis
11.3.9 MTI Onyx Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Liquid Embolic Materials Product Models, Descriptions and Specifications
11.4.4 Johnson & Johnson Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Johnson & Johnson Liquid Embolic Materials Sales by Product in 2024
11.4.6 Johnson & Johnson Liquid Embolic Materials Sales by Application in 2024
11.4.7 Johnson & Johnson Liquid Embolic Materials Sales by Geographic Area in 2024
11.4.8 Johnson & Johnson Liquid Embolic Materials SWOT Analysis
11.4.9 Johnson & Johnson Recent Developments
11.5 BALT Extrusion
11.5.1 BALT Extrusion Corporation Information
11.5.2 BALT Extrusion Business Overview
11.5.3 BALT Extrusion Liquid Embolic Materials Product Models, Descriptions and Specifications
11.5.4 BALT Extrusion Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BALT Extrusion Liquid Embolic Materials Sales by Product in 2024
11.5.6 BALT Extrusion Liquid Embolic Materials Sales by Application in 2024
11.5.7 BALT Extrusion Liquid Embolic Materials Sales by Geographic Area in 2024
11.5.8 BALT Extrusion Liquid Embolic Materials SWOT Analysis
11.5.9 BALT Extrusion Recent Developments
11.6 Merit Medical Systems
11.6.1 Merit Medical Systems Corporation Information
11.6.2 Merit Medical Systems Business Overview
11.6.3 Merit Medical Systems Liquid Embolic Materials Product Models, Descriptions and Specifications
11.6.4 Merit Medical Systems Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Merit Medical Systems Recent Developments
11.7 Guerbet
11.7.1 Guerbet Corporation Information
11.7.2 Guerbet Business Overview
11.7.3 Guerbet Liquid Embolic Materials Product Models, Descriptions and Specifications
11.7.4 Guerbet Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Guerbet Recent Developments
11.8 Terumo
11.8.1 Terumo Corporation Information
11.8.2 Terumo Business Overview
11.8.3 Terumo Liquid Embolic Materials Product Models, Descriptions and Specifications
11.8.4 Terumo Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Terumo Recent Developments
11.9 Penumbra
11.9.1 Penumbra Corporation Information
11.9.2 Penumbra Business Overview
11.9.3 Penumbra Liquid Embolic Materials Product Models, Descriptions and Specifications
11.9.4 Penumbra Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Penumbra Recent Developments
11.10 Sirtex
11.10.1 Sirtex Corporation Information
11.10.2 Sirtex Business Overview
11.10.3 Sirtex Liquid Embolic Materials Product Models, Descriptions and Specifications
11.10.4 Sirtex Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Sirtex Recent Developments
11.11 Sexs Biotech
11.11.1 Sexs Biotech Corporation Information
11.11.2 Sexs Biotech Business Overview
11.11.3 Sexs Biotech Liquid Embolic Materials Product Models, Descriptions and Specifications
11.11.4 Sexs Biotech Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Sexs Biotech Recent Developments
11.12 Zhuhai Shenping Medical
11.12.1 Zhuhai Shenping Medical Corporation Information
11.12.2 Zhuhai Shenping Medical Business Overview
11.12.3 Zhuhai Shenping Medical Liquid Embolic Materials Product Models, Descriptions and Specifications
11.12.4 Zhuhai Shenping Medical Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Zhuhai Shenping Medical Recent Developments
11.13 Yuanda Pharmaceutical
11.13.1 Yuanda Pharmaceutical Corporation Information
11.13.2 Yuanda Pharmaceutical Business Overview
11.13.3 Yuanda Pharmaceutical Liquid Embolic Materials Product Models, Descriptions and Specifications
11.13.4 Yuanda Pharmaceutical Liquid Embolic Materials Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Yuanda Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Liquid Embolic Materials Industry Chain
12.2 Liquid Embolic Materials Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Liquid Embolic Materials Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Liquid Embolic Materials Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Liquid Embolic Materials Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Liquid Embolic Materials Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Liquid Embolic Materials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Liquid Embolic Materials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Liquid Embolic Materials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Liquid Embolic Materials Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Liquid Embolic Materials Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Liquid Embolic Materials Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Liter)
Table 7. Global Liquid Embolic Materials Sales by Region (2020-2025) & (Liter)
Table 8. Global Liquid Embolic Materials Sales by Region (2026-2031) & (Liter)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Liquid Embolic Materials Sales by Manufacturers (2020-2025) & (Liter)
Table 11. Global Liquid Embolic Materials Sales Share by Manufacturers (2020-2025)
Table 12. Global Liquid Embolic Materials Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Liquid Embolic Materials Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Liquid Embolic Materials by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Embolic Materials as of 2024)
Table 16. Global Liquid Embolic Materials Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Liquid Embolic Materials Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/ml)
Table 18. Key Manufacturers Liquid Embolic Materials Manufacturing Base and Headquarters
Table 19. Global Liquid Embolic Materials Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Liquid Embolic Materials Sales by Type (2020-2025) & (Liter)
Table 23. Global Liquid Embolic Materials Sales by Type (2026-2031) & (Liter)
Table 24. Global Liquid Embolic Materials Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Liquid Embolic Materials Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Liquid Embolic Materials ASP by Type (2020-2031) & (US$/ml)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Liquid Embolic Materials Sales by Application (2020-2025) & (Liter)
Table 29. Global Liquid Embolic Materials Sales by Application (2026-2031) & (Liter)
Table 30. Liquid Embolic Materials High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Liquid Embolic Materials Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Liquid Embolic Materials Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Liquid Embolic Materials ASP by Application (2020-2031) & (US$/ml)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Liquid Embolic Materials Growth Accelerators and Market Barriers
Table 37. North America Liquid Embolic Materials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Liquid Embolic Materials Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Liquid Embolic Materials Growth Accelerators and Market Barriers
Table 40. Europe Liquid Embolic Materials Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Liquid Embolic Materials Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Liquid Embolic Materials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Liquid Embolic Materials Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Liquid Embolic Materials Growth Accelerators and Market Barriers
Table 45. Southeast Asia Liquid Embolic Materials Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Liquid Embolic Materials Investment Opportunities and Key Challenges
Table 47. Central and South America Liquid Embolic Materials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Liquid Embolic Materials Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Liquid Embolic Materials Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Liquid Embolic Materials SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. Boston Scientific Corporation Information
Table 60. Boston Scientific Description and Major Businesses
Table 61. Boston Scientific Product Models, Descriptions and Specifications
Table 62. Boston Scientific Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 63. Boston Scientific Sales Value Proportion by Product in 2024
Table 64. Boston Scientific Sales Value Proportion by Application in 2024
Table 65. Boston Scientific Sales Value Proportion by Geographic Area in 2024
Table 66. Boston Scientific Liquid Embolic Materials SWOT Analysis
Table 67. Boston Scientific Recent Developments
Table 68. MTI Onyx Corporation Information
Table 69. MTI Onyx Description and Major Businesses
Table 70. MTI Onyx Product Models, Descriptions and Specifications
Table 71. MTI Onyx Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 72. MTI Onyx Sales Value Proportion by Product in 2024
Table 73. MTI Onyx Sales Value Proportion by Application in 2024
Table 74. MTI Onyx Sales Value Proportion by Geographic Area in 2024
Table 75. MTI Onyx Liquid Embolic Materials SWOT Analysis
Table 76. MTI Onyx Recent Developments
Table 77. Johnson & Johnson Corporation Information
Table 78. Johnson & Johnson Description and Major Businesses
Table 79. Johnson & Johnson Product Models, Descriptions and Specifications
Table 80. Johnson & Johnson Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 81. Johnson & Johnson Sales Value Proportion by Product in 2024
Table 82. Johnson & Johnson Sales Value Proportion by Application in 2024
Table 83. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
Table 84. Johnson & Johnson Liquid Embolic Materials SWOT Analysis
Table 85. Johnson & Johnson Recent Developments
Table 86. BALT Extrusion Corporation Information
Table 87. BALT Extrusion Description and Major Businesses
Table 88. BALT Extrusion Product Models, Descriptions and Specifications
Table 89. BALT Extrusion Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 90. BALT Extrusion Sales Value Proportion by Product in 2024
Table 91. BALT Extrusion Sales Value Proportion by Application in 2024
Table 92. BALT Extrusion Sales Value Proportion by Geographic Area in 2024
Table 93. BALT Extrusion Liquid Embolic Materials SWOT Analysis
Table 94. BALT Extrusion Recent Developments
Table 95. Merit Medical Systems Corporation Information
Table 96. Merit Medical Systems Description and Major Businesses
Table 97. Merit Medical Systems Product Models, Descriptions and Specifications
Table 98. Merit Medical Systems Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 99. Merit Medical Systems Recent Developments
Table 100. Guerbet Corporation Information
Table 101. Guerbet Description and Major Businesses
Table 102. Guerbet Product Models, Descriptions and Specifications
Table 103. Guerbet Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 104. Guerbet Recent Developments
Table 105. Terumo Corporation Information
Table 106. Terumo Description and Major Businesses
Table 107. Terumo Product Models, Descriptions and Specifications
Table 108. Terumo Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 109. Terumo Recent Developments
Table 110. Penumbra Corporation Information
Table 111. Penumbra Description and Major Businesses
Table 112. Penumbra Product Models, Descriptions and Specifications
Table 113. Penumbra Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 114. Penumbra Recent Developments
Table 115. Sirtex Corporation Information
Table 116. Sirtex Description and Major Businesses
Table 117. Sirtex Product Models, Descriptions and Specifications
Table 118. Sirtex Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 119. Sirtex Recent Developments
Table 120. Sexs Biotech Corporation Information
Table 121. Sexs Biotech Description and Major Businesses
Table 122. Sexs Biotech Product Models, Descriptions and Specifications
Table 123. Sexs Biotech Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 124. Sexs Biotech Recent Developments
Table 125. Zhuhai Shenping Medical Corporation Information
Table 126. Zhuhai Shenping Medical Description and Major Businesses
Table 127. Zhuhai Shenping Medical Product Models, Descriptions and Specifications
Table 128. Zhuhai Shenping Medical Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 129. Zhuhai Shenping Medical Recent Developments
Table 130. Yuanda Pharmaceutical Corporation Information
Table 131. Yuanda Pharmaceutical Description and Major Businesses
Table 132. Yuanda Pharmaceutical Product Models, Descriptions and Specifications
Table 133. Yuanda Pharmaceutical Sales (Liter), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2020-2025)
Table 134. Yuanda Pharmaceutical Recent Developments
Table 135. Key Raw Materials Distribution
Table 136. Raw Materials Key Suppliers
Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 138. Milestones in Production Technology Evolution
Table 139. Distributors List
Table 140. Market Trends and Market Evolution
Table 141. Market Drivers and Opportunities
Table 142. Market Challenges, Risks, and Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Liquid Embolic Materials Product Picture
Figure 2. Global Liquid Embolic Materials Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Adhesive Product Picture
Figure 4. Non-adhesive Product Picture
Figure 5. Global Liquid Embolic Materials Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Neurovascular Interventional Treatment
Figure 7. Tumor Interventional Treatment
Figure 8. Other
Figure 9. Liquid Embolic Materials Report Years Considered
Figure 10. Global Liquid Embolic Materials Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 12. Global Liquid Embolic Materials Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Liquid Embolic Materials Revenue Market Share by Region (2020-2031)
Figure 14. Global Liquid Embolic Materials Sales (2020-2031) & (Liter)
Figure 15. Global Liquid Embolic Materials Sales (CAGR) by Region (2020-2031) (Liter)
Figure 16. Global Liquid Embolic Materials Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Liquid Embolic Materials Sales Volume Market Share in 2024
Figure 18. Global Liquid Embolic Materials Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Adhesive Revenue Market Share by Manufacturer in 2024
Figure 21. Non-adhesive Revenue Market Share by Manufacturer in 2024
Figure 22. Global Liquid Embolic Materials Sales Market Share by Type (2020-2031)
Figure 23. Global Liquid Embolic Materials Revenue Market Share by Type (2020-2031)
Figure 24. Global Liquid Embolic Materials Sales Market Share by Application (2020-2031)
Figure 25. Global Liquid Embolic Materials Revenue Market Share by Application (2020-2031)
Figure 26. North America Liquid Embolic Materials Sales YoY (2020-2031) & (Liter)
Figure 27. North America Liquid Embolic Materials Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Liquid Embolic Materials Sales Revenue (US$ Million) in 2024
Figure 29. North America Liquid Embolic Materials Sales Volume (Liter) by Type (2020- 2031)
Figure 30. North America Liquid Embolic Materials Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Liquid Embolic Materials Sales Volume (Liter) by Application (2020-2031)
Figure 32. North America Liquid Embolic Materials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Liquid Embolic Materials Sales YoY (2020-2031) & (Liter)
Figure 37. Europe Liquid Embolic Materials Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Liquid Embolic Materials Sales Revenue (US$ Million) in 2024
Figure 39. Europe Liquid Embolic Materials Sales Volume (Liter) by Type (2020-2031)
Figure 40. Europe Liquid Embolic Materials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Liquid Embolic Materials Sales Volume (Liter) by Application (2020-2031)
Figure 42. Europe Liquid Embolic Materials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 44. France Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Liquid Embolic Materials Sales YoY (2020-2031) & (Liter)
Figure 49. Asia-Pacific Liquid Embolic Materials Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Liquid Embolic Materials Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Liquid Embolic Materials Sales Volume (Liter) by Type (2020- 2031)
Figure 52. Asia-Pacific Liquid Embolic Materials Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Liquid Embolic Materials Sales Volume (Liter) by Application (2020-2031)
Figure 54. Asia-Pacific Liquid Embolic Materials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 59. India Liquid Embolic Materials Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Liquid Embolic Materials Sales YoY (2020-2031) & (Liter)
Figure 61. Central and South America Liquid Embolic Materials Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Liquid Embolic Materials Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Liquid Embolic Materials Sales Volume (Liter) by Type (2021-2031)
Figure 64. Central and South America Liquid Embolic Materials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Liquid Embolic Materials Sales Volume (Liter) by Application (2020-2031)
Figure 66. Central and South America Liquid Embolic Materials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Liquid Embolic Materials Sales YoY (2020-2031) & (Liter)
Figure 70. Middle East and Africa Liquid Embolic Materials Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Liquid Embolic Materials Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Liquid Embolic Materials Sales Volume (Liter) by Type (2021-2031)
Figure 73. South America Liquid Embolic Materials Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Liquid Embolic Materials Sales Volume (Liter) by Application (2020-2031)
Figure 75. Middle East and Africa Liquid Embolic Materials Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Liquid Embolic Materials Revenue (2020-2025) & (US$ Million)
Figure 80. Liquid Embolic Materials Industry Chain Mapping
Figure 81. Regional Liquid Embolic Materials Manufacturing Base Distribution (%)
Figure 82. Global Liquid Embolic Materials Production Market Share by Region (2020-2031)
Figure 83. Liquid Embolic Materials Production Process
Figure 84. Regional Liquid Embolic Materials Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
